Open Access‘Non-Debate’ Highlights Drawbacks of High-Dose Dexamethasone in Myeloma
Author(s) -
Robert H. Carlson
Publication year - 2008
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000311427.60208.52
Subject(s) - dexamethasone , multiple myeloma , regimen , medicine , lenalidomide , bortezomib , population , hematology , thalidomide , oncology , environmental health